Aspen Neuroscience, Inc. Common Stock (ASPE)

• Market cap: $433M
• 1 day: 0%
• 5 days: 1.29%
• 1 month: 0%
• 3 months: 0%
• 6 months: 0%
• Year to date: 0%
• 1 year: 0%
• 5 years: 0%
• 10 years: 0%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.